Literature DB >> 8789739

Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.

J Eberle1, C Garbe, N Wang, C E Orfanos.   

Abstract

Sequence analysis of two clones found repressed in melanoma cell lines in earlier studies showed 9F2 to be identical with the TRP-1 gene and 6F5 with TRP-2 containing a long untranslated 3' end. For further investigation of the expression of the tyrosinase gene family in normal and malignant melanocytic cells, a series of melanoma cell lines and of cultured melanocytes were analyzed by Northern blotting and by reverse transcriptase-polymerase chain reaction (RT-PCR). The Northern blots were probed with cDNA fragments specific for TRP-1, TRP-2, and tyrosinase, for nested tyrosinase-PCR the outer primers specified a 284 bp and the nested primers a 207 bp fragment. Investigations on 14 established melanoma cell lines grown in different media compared with seven normal human melanocyte (NHM) cultures revealed that all three pigment genes were expressed in NHM, whereas pigment gene expression was found repressed in nearly all melanoma cell lines and was completely absent in 4 of 14 specimen. In particular, tyrosinase and TRP-2 genes were found always to be expressed together, and TRP-1 mRNA alone was absent in four melanoma cell lines. Negativity of cultured melanoma cells for tyrosinase mRNA was confirmed by nested RT-PCR, and gene deletion was ruled out by genomic Southern blots. The gene expression seemed independent from the type of medium used for cultivation. These findings indicate repressed or lacking expression of pigment genes in melanoma cell lines, most likely due to regulatory mechanisms, and that differences may exist between tyrosinase and TRP-2 on one hand and TRP-1 on the other. Overall, it seemed that RT-PCR for tyrosinase has limited value for identifying melanoma cells in the peripheral blood of melanoma patients; TRP-1, TRP-2, and other, additional markers may be required.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789739     DOI: 10.1111/j.1600-0749.1995.tb00679.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  7 in total

1.  Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.

Authors:  R Halaban; E Cheng; Y Zhang; G Moellmann; D Hanlon; M Michalak; V Setaluri; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.

Authors:  C Olivares; C Jiménez-Cervantes; J A Lozano; F Solano; J C García-Borrón
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

3.  Inhibitory effects and underlying mechanisms of Artemisia capillaris essential oil on melanogenesis in the B16F10 cell line.

Authors:  Min Jae Kim; Elsayed A Mohamed; Da Som Kim; Mi-Jin Park; Byoung-Jun Ahn; Eui-Bae Jeung; Beum-Soo An
Journal:  Mol Med Rep       Date:  2022-02-09       Impact factor: 2.952

4.  Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Authors:  B Keenen; H Qi; S V Saladi; M Yeung; I L de la Serna
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

5.  Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.

Authors:  R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

6.  Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1.

Authors:  J Eberle; L F Fecker; J-U Bittner; C E Orfanos; C C Geilen
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

7.  Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis.

Authors:  Beatrice Tolksdorf; Sina Zarif; Jürgen Eberle; Ahmet Hazini; Babette Dieringer; Franziska Jönsson; Florian Kreppel; Jens Kurreck; Henry Fechner
Journal:  J Mol Med (Berl)       Date:  2021-05-24       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.